Target intelligence / Profile preview

GPC6 antisense RNA 1 (GPC6-AS1)

Target
GPC6-AS1
Molecular classification
Long non-coding RNA (lncRNA), Antisense RNA, Non-protein coding RNA
01

Overview

GPC6 antisense RNA 1 (GPC6-AS1) is a long non-coding RNA belonging to the antisense RNA family, transcribed from the opposite strand of the GPC6 gene locus on human chromosome 13[3][5]. Like other lncRNA antisense transcripts, it does not code for protein but may regulate the expression of its sense counterpart (GPC6) or other genes through mechanisms such as chromatin modulation or post-transcriptional RNA duplex formation[2][4][6]. Antisense lncRNAs can impact gene expression via recruitment of transcriptional or chromatin-modifying complexes, modulation of mRNA stability, or translational regulation, but specific molecular details, biological functions, or disease associations for GPC6-AS1 have not been functionally validated or experimentally characterized in the search results. No drugs, biomarker roles, or therapeutic safety issues are currently associated with this gene. If structured information or detailed functional characterization of GPC6-AS1 becomes available in the future, this status may change; for now, GPC6-AS1 is best classified as a non-coding regulatory RNA of uncertain biological and clinical significance[3][5].

Other names
GPC6-AS1GPC6 antisense RNA 1 (non-protein coding)GPC6 antisense RNA 1
02

Mechanism of action

not applicable; as a non-coding RNA, GPC6-AS1 is not a direct drug target and has no canonical drug mechanisms

03

Biological functions

Regulation of gene expression at the transcriptional and/or post-transcriptional levelPotential modulation of mRNA stability and translationPossible participation in cis or trans gene regulatory effects, such as chromatin remodeling or recruitment of chromatin modifiers
04

Disease associations

Possible role in Hypophosphatasia (gene-disease association, little functional detail)By analogy with similar antisense lncRNAs, possible roles in cancer and other diseases related to the regulation of the sense gene (GPC6), but no direct evidence for GPC6-AS1 specifically was found in the search results

Beyond the preview

Go deeper on GPC6 antisense RNA 1 (GPC6-AS1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on GPC6 antisense RNA 1 (GPC6-AS1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call